Literature DB >> 21034967

microRNAs in cancer: from bench to bedside.

Maria Angelica Cortez1, Cristina Ivan, Peng Zhou, Xue Wu, Mircea Ivan, George Adrian Calin.   

Abstract

microRNAs (miRNAs) are master regulators of gene expression. By degrading or blocking translation of messenger RNA targets, these noncoding RNAs can regulate the expression of more than half of all protein-coding genes in mammalian genomes. Aberrant miRNA expression is well characterized in cancer progression and has prognostic implications for cancer in general. Over the past several years, accumulating evidence has demonstrated that genomic alterations in miRNA genes are correlated with all aspects of cancer biology. In this review, we describe the effects of miRNA deregulation in the cellular pathways that lead to the progressive conversion of normal cells into cancer cells as well as in cancer diagnosis and therapy in humans.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21034967     DOI: 10.1016/B978-0-12-380888-2.00004-2

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  20 in total

Review 1.  Human papillomavirus and cervical cancer: biomarkers for improved prevention efforts.

Authors:  Vikrant V Sahasrabuddhe; Patricia Luhn; Nicolas Wentzensen
Journal:  Future Microbiol       Date:  2011-09       Impact factor: 3.165

Review 2.  [Pathobiology of the microRNA system].

Authors:  K Hussein
Journal:  Pathologe       Date:  2012-02       Impact factor: 1.011

3.  miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.

Authors:  Tsai-Der Chuang; Xiaoping Luo; Harekrushna Panda; Nasser Chegini
Journal:  Mol Endocrinol       Date:  2012-05-03

4.  Evaluation of SNPs in miR-196-a2, miR-27a and miR-146a as risk factors of colorectal cancer.

Authors:  Renata Hezova; Alena Kovarikova; Julie Bienertova-Vasku; Milana Sachlova; Martina Redova; Anna Vasku; Marek Svoboda; Lenka Radova; Igor Kiss; Rostislav Vyzula; Ondrej Slaby
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

Review 5.  The role of MicroRNA molecules and MicroRNA-regulating machinery in the pathogenesis and progression of epithelial ovarian cancer.

Authors:  Xiyin Wang; Mircea Ivan; Shannon M Hawkins
Journal:  Gynecol Oncol       Date:  2017-08-31       Impact factor: 5.482

6.  Gastric adenocarcinoma has a unique microRNA signature not present in esophageal adenocarcinoma.

Authors:  Zheng Chen; Rama Saad; Peilin Jia; DunFa Peng; Shoumin Zhu; M Kay Washington; Zhongming Zhao; Zekuan Xu; Wael El-Rifai
Journal:  Cancer       Date:  2013-03-01       Impact factor: 6.860

7.  microRNA-based cancer cell reprogramming technology.

Authors:  Shimpei Nishikawa; Hideshi Ishii; Naotsugu Haraguchi; Yoshihiro Kano; Takahito Fukusumi; Katsuya Ohta; Miyuki Ozaki; Dyah Laksmi Dewi; Daisuke Sakai; Taroh Satoh; Hiroaki Nagano; Yuichiro Doki; Masaki Mori
Journal:  Exp Ther Med       Date:  2012-04-23       Impact factor: 2.447

8.  miR-124 and Androgen Receptor Signaling Inhibitors Repress Prostate Cancer Growth by Downregulating Androgen Receptor Splice Variants, EZH2, and Src.

Authors:  Xu-Bao Shi; Ai-Hong Ma; Lingru Xue; Meimei Li; Hao G Nguyen; Joy C Yang; Clifford G Tepper; Regina Gandour-Edwards; Christopher P Evans; Hsing-Jien Kung; Ralph W deVere White
Journal:  Cancer Res       Date:  2015-11-16       Impact factor: 12.701

9.  miR-200c inhibits melanoma progression and drug resistance through down-regulation of BMI-1.

Authors:  Shujing Liu; Michael T Tetzlaff; Rutao Cui; Xiaowei Xu
Journal:  Am J Pathol       Date:  2012-09-13       Impact factor: 4.307

10.  Suffocating cancer: hypoxia-associated epimutations as targets for cancer therapy.

Authors:  C Thirlwell; Lke Schulz; Hk Dibra; S Beck
Journal:  Clin Epigenetics       Date:  2011-12-05       Impact factor: 6.551

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.